Back

prof. dr. E. (E.) van der Wall

Full Professor

  • Speerpunt Cancer

prof. dr. E. (E.) van der Wall

Research Programs

Biography

Elsken van der Wall (1960)  has studied medicine at the University of Utrecht and subsequently specialized in internal medicine at the University Medical Center of Utrecht.

In the Dutch Cancer Institute / Het Antoni van Leeuwenhoekhuis in Amsterdam she further specialized in medical oncology while performing research that resulted in her PhD degree on ‘high-dose chemotherapy in solid tumors’ in 1995. From 1995 till 2003 she held a position as medical oncologist at the department of medical oncology at the VU Medical Center in Amsterdam. During this time she spend 14 months as a basic scientist at the Sidney Kimmel Cancer Institute at Johns Hopkins Medical Institutions (JHMI) in Baltimore, USA . Following her stay at the Sidney Kimmel Cancer Institute she became part-time associate professor at JHMI which position she still helds.

In 2003 she was appointed full professor of medicine at the University Medical Center Utrecht (UMCU) and head of the specialization program in internal medicine. In addition, she became member of the management team of the Division of Internal Medicine and Dermatology of the UMCU, responsible for research and education development within the Division. In 2005, she was appointed as distinguished professor of Utrecht University. In 2007 she left the specialization program in internal medicine and became head of the Cancer Center of the UMC Utrecht. As of 2018 she was appointend chair of the Strategic Program Cancer. Her out-patient clinical activities focus entirely on patients with breast cancer. Together with prof. dr. Paul van Diest, head of the Department of Pathology, she supervises the laboratory for breast cancer research at the UMC Utrecht. The focus of her scientific research is on breast carcinogenesis and she is co-author of over 200 peer-reviewed scientific papers. Outside her regular work she holds various positions that, amongst others, include: member of the Medical Advisory Board of the Dutch Cancer Center Network and member of the Advisory Board of the Dutch Cancer Foundation.. In 2010 she was knighted by former HRM Queen Beatrix of the Netherlands, for her contribution to increase breast cancer awareness. In 2015 she received the “Corrie Herman” award, a national award to honour female medical role-models. In 2019 she was awarded with the Supervisor ( promotor) of the Year 2019.

 

Side Activities

  • 1999 - visiting professor at the Sidney Kimmel Cancer Institute at Johns Hopkins Medical Institutions (JHMI) in Baltimore, USA
    2005 - Distinguished professor of Utrecht University
    2013 - member of the Medical Advisory Board of the Dutch Cancer Center Network
    2019 - member of the KWF Advisory Board
    2019 - member of the Scientific Advisory Board PMC / UMC Utrecht

Fellowship and Awards

  • 2010 - knighted by former HRM Queen Beatrix of the Netherlands, for her contribution to increase breast cancer awareness.

    2014 - Corry Hermann Award – Annual Award by the Dutch Female Medical Professionals Association

    Research-grants received for over 12 m euro’s, including  from the Dutch cancer Foundation, NWO and private funds.

    2019 - PhD supervisor of the year of the Graduate School of Life Sciences of the UU

Research Output (219)

Tumor Response After Neoadjuvant Magnetic Resonance Guided Single Ablative Dose Partial Breast Irradiation

Vasmel Jeanine E, Charaghvandi Ramona K, Houweling Antonetta C, Philippens Marielle EP, van Asselen Bram, Vreuls Celien PH, van Diest Paul J, van Leeuwen Am Gijs, van Gorp Joost, Witkamp Arjen J, Koelemij Ron, Doeksen Annemiek, Sier Maartje F, van Dalen Thijs, van der Wall Elsken, van Dam Iris, Veldhuis Wouter B, Kirby Anna M, Verkooijen Helena M, van den Bongard HJG Desiree 15 mrt 2020, In: International Journal of Radiation Oncology Biology Physics. 106 , p. 821-829 9 p.

Off to a good start after a cancer diagnosis:implementation of a time out consultation in primary care before cancer treatment decision

Noteboom Eveline A., De Wit Niek J., Van Asseldonk Ingrid J. E. M., Janssen Monique C. A. M., Lam-Wong Wai Yee, Linssen Rob H. P. J., Pepels Manon J. A. E., Schrama Natascha A. W. P., Trompper Marielle E. H., Veldhuizen L. Maaike, Wijtvliet Anne P., Zeldenrust Ed G. F., Hendrikx Ans M., Van de Boomen Wil A., Elbersen Dorothe M., Jacobs Esther M. G., Van der Wall Elsken, Helsper Charles W. 16 nov 2019, In: Journal of cancer survivorship : research and practice. 14 , p. 9-13 5 p.

Application of Nipple Aspirate Fluid miRNA Profiles for Early Breast Cancer Detection and Management

Moelans Cathy B, Patuleia Susana I S, van Gils Carla H, van der Wall Elsken, van Diest Paul J 2 nov 2019, In: International journal of molecular sciences. 20

Doxorubicin-induced skeletal muscle atrophy:elucidating the underlying molecular pathways

Hiensch Anouk E, Bolam Kate A, Mijwel Sara, Jeneson Jeroen A L, Huitema Alwin D R, Kranenburg Onno, van der Wall Elsken, Rundqvist Helene, Wengstrom Yvonne, May Anne M 10 okt 2019, In: Acta physiologica (Oxford, England). 229 18 p.

The molecular genetic make-up of male breast cancer

Moelans Cathy B., de Ligt Joep, van der Groep Petra, Prins Pjotr, Besselink Nicolle J. M., Hoogstraat Marlous, ter Hoeve Natalie D., Lacle Miangela M., Kornegoor Robert, van der Pol Carmen C., de Leng Wendy W. J., Barbe Ellis, van der Vegt Bert, Martens John, Bult Peter, Smit Vincent T. H. B. M., Koudijs Marco J., Nijman Isaac J., Voest Emile E., Selenica Pier, Weigelt Britta, Reis-Filho Jorge S., van der Wall Elsken, Cuppen Edwin, van Diest Paul J. okt 2019, In: Endocrine-Related Cancer. 26 , p. 779-794 16 p.

The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer

van Steenhoven J E C, Kuijer A, Schreuder K, Elias S G, van Diest P J, van der Wall E, Siesling S, van Dalen T okt 2019, In: Annals of Surgical Oncology. 26 , p. 3495-3501 7 p.

The Use of Expectancy and Empathy When Communicating With Patients With Advanced Breast Cancer; an Observational Study of Clinician-Patient Consultations

van Vliet Liesbeth Mirjam, Francke Anneke L, Meijers Maartje C, Westendorp Janine, Hoffstädt Hinke, Evers Andrea W M, van der Wall Elsken, de Jong Paul, Peerdeman Kaya J, Stouthard Jacqueline, van Dulmen Sandra 17 jul 2019, In: Frontiers in Psychiatry. 10

Hormone- and HER2-receptor assessment in 33,046 breast cancer patients:a nationwide comparison of positivity rates between pathology laboratories in the Netherlands

van Dooijeweert Carmen, Deckers Ivette A.G., Baas Inge O., van der Wall Elsken, van Diest Paul J. 15 jun 2019, In: Breast Cancer Research and Treatment. 175 , p. 487-497 11 p.

Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study):protocol of a randomised controlled trial

Witlox Lenja, Schagen Sanne B, de Ruiter Michiel B, Geerlings Mirjam I, Peeters Petra H M, Koevoets Emmie W, van der Wall Elsken, Stuiver Martijn, Sonke Gabe, Velthuis Miranda J, Palen Job A M van der, Jobsen Jan J, May Anne M, Monninkhof E M 1 jun 2019, In: BMJ Open. 9

Involving the general practitioner during curative cancer treatment:a systematic review of health care interventions

Perfors Ietje A. A., May Anne M., Boeijen Josi A., de Wit Niek J., van der Wall Elsken, Helsper Charles W. 14 apr 2019, In: BMJ Open. 9

All Research Output (219)